• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy for older women with node-positive breast cancer.

作者信息

Ginsburg D

出版信息

CMAJ. 2001 Sep 4;165(5):525, 527.

PMID:11563200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC81402/
Abstract
摘要

相似文献

1
Chemotherapy for older women with node-positive breast cancer.老年淋巴结阳性乳腺癌女性的化疗
CMAJ. 2001 Sep 4;165(5):525, 527.
2
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).乳腺癌护理与治疗临床实践指南：淋巴结阴性乳腺癌的辅助全身治疗（2001年更新版摘要）
CMAJ. 2001 Jan 23;164(2):213.
3
Advances in adjuvant hormonal therapy for postmenopausal women.绝经后女性辅助激素治疗的进展
J Clin Oncol. 2005 Mar 10;23(8):1751-9. doi: 10.1200/JCO.2005.11.038.
4
[Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].[绝经后原发性可手术乳腺癌女性的辅助抗激素治疗]
Ugeskr Laeger. 2007 Jan 22;169(4):297-9.
5
The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.早期乳腺癌辅助激素治疗的最佳持续时间。
Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4.
6
Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.比较绝经后乳腺癌辅助内分泌治疗指南：崭露头角。
Expert Rev Anticancer Ther. 2011 Feb;11(2):277-86. doi: 10.1586/era.10.218.
7
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.他莫昔芬与辅助性风险适应性化疗后绝经后、受体阴性乳腺癌患者对照：一项随机试验（GABG-IV D-93）——德国辅助性乳腺癌研究组
J Clin Oncol. 2005 Nov 1;23(31):7842-8. doi: 10.1200/JCO.2005.01.3433.
8
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.利用雌激素受体信息在美国推广乳腺癌辅助多药化疗和他莫昔芬：1975 - 1999年
J Natl Cancer Inst Monogr. 2006(36):7-15. doi: 10.1093/jncimonographs/lgj003.
9
Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.乳腺癌内分泌治疗的当前概念：他莫昔芬和芳香化酶抑制剂。
J Clin Pharm Ther. 2005 Aug;30(4):313-7. doi: 10.1111/j.1365-2710.2005.00655.x.
10
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.接受辅助性他莫昔芬治疗的雌激素受体阳性早期乳腺癌绝经后女性的早期复发风险。
Cancer. 2008 Apr 1;112(7):1437-44. doi: 10.1002/cncr.23320.

本文引用的文献

1
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.乳腺癌护理与治疗临床实践指南：淋巴结阳性乳腺癌的辅助全身治疗（2001年更新摘要）。乳腺癌护理与治疗临床实践指南指导委员会。
CMAJ. 2001 Mar 6;164(5):644-6.
2
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.表柔比星联合他莫昔芬与单纯他莫昔芬治疗绝经后淋巴结阳性乳腺癌患者的疗效比较：国际癌症协作组的一项随机试验
J Clin Oncol. 1999 Jul;17(7):1988-98. doi: 10.1200/JCO.1999.17.7.1988.
3
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.早期乳腺癌的多药化疗：随机试验综述。早期乳腺癌试验者协作组
Lancet. 1998 Sep 19;352(9132):930-42.
4
Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.辅助化疗联合他莫昔芬治疗绝经后淋巴结阳性乳腺癌患者的疗效
J Clin Oncol. 1997 Apr;15(4):1385-94. doi: 10.1200/JCO.1997.15.4.1385.
5
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Lancet. 1984 Jun 9;1(8389):1256-60.
6
Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience.原发性可手术乳腺癌治疗中的全身辅助治疗：国家外科辅助乳腺和肠道项目经验
NCI Monogr. 1986(1):35-43.
7
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.在50岁及以上对他莫昔芬敏感的阳性淋巴结乳腺癌患者中，术后化疗联合他莫昔芬与单纯他莫昔芬治疗的比较：美国国家外科辅助乳腺和肠道项目B-16的结果
J Clin Oncol. 1990 Jun;8(6):1005-18. doi: 10.1200/JCO.1990.8.6.1005.
8
Hormonal versus chemohormonal adjuvant therapy in node-positive postmenopausal patients.激素疗法与化疗联合激素辅助疗法用于绝经后淋巴结阳性患者的疗效比较
J Clin Oncol. 1990 Nov;8(11):1922, 1925-6.